Prasequine 1 mg tablets for horses
Prasequine 1 mg tablets for horses
Authorised
- Pergolide
Product identification
Medicine name:
Prasequine 1 mg tablets for horses
Prasequine, 1 mg tabletid hobustele
Active substance:
- Pergolide
Target species:
-
Horse (non food-producing)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Pergolide1.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Horse (non food-producing)
-
Not applicableno withdrawal periodNot authorised for use in horses intended for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation. Not authorised for use in mares producing milk for human consumption.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN04BC02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- Carton box containing 13 OPA/aluminium/PVC-aluminium blisters, containing 7 tablets each
- Carton box containing 24 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each
- Carton box containing 16 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each
- Carton box containing 10 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each
- Carton box containing 6 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic (abridged application) - art 13(1)
Marketing authorisation holder:
- CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
- CP-Pharma Handelsgesellschaft mbH
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1091522
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0368/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Norway
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: